Sep 18 |
IGM Biosciences: Waiting For Godot
|
Sep 18 |
IGM Biosciences (IGMS) Surges 11.6%: Is This an Indication of Further Gains?
|
Sep 10 |
IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit
|
Aug 22 |
All You Need to Know About IGM Biosciences (IGMS) Rating Upgrade to Buy
|
Aug 14 |
IGM Biosciences, Inc. (IGMS) Reports Q2 Loss, Lags Revenue Estimates
|
Aug 14 |
IGM Biosciences GAAP EPS of -$0.79, revenue of $1.26M
|
Aug 14 |
IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update
|
Jul 12 |
IGM Biosciences (IGMS) Soars 32.7%: Is Further Upside Left in the Stock?
|
Jun 5 |
Shareholders May Find It Hard To Justify Increasing IGM Biosciences, Inc.'s (NASDAQ:IGMS) CEO Compensation For Now
|
May 30 |
We're Keeping An Eye On IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate
|